•  
  •  
 

Abstract

Introduction. HIV infection attacks the center of immune control system resulting opportunistic infection, malignancy and death. Immune system dysregulation plays the central role in the progression of the disease. Some studies reported that HIV-infected patient prone to have allergic disease such as sinusitis, asthma and atopic dermatitis. Elevated serum immunoglobulin E (IgE) and increased prevalence of atopy had also been reported in HIV-infected patient. Methods. A cross sectional study was performed in 92 HIV-infected persons and 90 non-HIV persons. Atopy diagnosis was based on immediate hypersensitivity to six common aeroallergen using skin prick test. CD4 cell count, total serum immunoglobulin level and medical history were taken. Results. Among total of 92 HIV/AIDS patients and 90 non-HIV persons, there were 65 males (70.7%) and 27 female (29.3%) in HIV group and 40 males (44.4%) and 50 females (55.6%) in non-HIV group. Age of all subjects range from 20 to 55 years old, mean age of HIV-infected patients was 29.3 (SD 5.7) years while mean age of controls was 27.9 (4.5) years old. Based on HIV route transmission, there were 56.5% subjects infected from intravenous drug user, 38% from heterosexual intercourse and 5.5% subjects had both risk. CD4+ lymphocyte counts of the subject range from 2-674 cells, median 160 cells/uL. Serum total IgE levels range from 3-20.000 IU/mL with median 283.5 IU/mL. Atopy was higher in subjects with HIV than non-HIV (p= 0,001). The most common aeroallergen is Dermatophagoides farinae (50%) and Dermatophagoides pteronyssinus (30%). There was a negative correlation between CD4+ lymphocyte count and total IgE level (r=-0,544, p<0,001), but there is no relation between gender, HIV route of transmission, allergic history in family and CD4+ lymphocyte count with atopy. Conclusions. Prevalence of atopy based on skin prick test among HIV/AIDS patients was higher than non-HIV group. There was a negative correlation between CD4+ lymphocyte count and total IgE level.

References

1. Gallo CR. Human retroviruses after 20 years: a perspective from the past and prospects for their future control. Immunol Rev. 2002:185:236-65. 2. Pirmohamed M, Park BK. HIV and drug allergy. Curr Opin Allergy Clin Immunol. 2001:1(4):311-6. 3. Carr A, Cooper DA, Penny R. Allergic manifestations of human immunodeficiency virus (HIV) infection. J Clin Immunol. 1991:11(2):55-64. 4. Coopman SA, Johnsin RA, Platt RA, Stern RS. Cutaneus Disease and Drug Reaction in HIV Infection. N Eng J Med. 1993;328(23):1670-4. 5. Garcia-Rodriguez JF, Corominas M, Fernandez-Viladrich P, Monfort JL, Dicenta M. Rhinosinusitis and atopy in patient infected with HIV. Laryngoscope. 1999;109(6):939-44. 6. Poirier CD, Inhaber N, Lalonde RG, Ernst P. Prevalence of Bronchial Hyperresponsiveness among HIV infected Men. Am J Respir Crit Care Med. 2001;164(4):542-5. 7. Lin RY, Lazarus TS. Asthma and related atopic disorders in outpatients attending an urban HIV clinic. Ann Allergy. 1995;74(6):510-5. 8. Wright DN, Nelson RP, Ledford DK, Fernandez CE, Trudeau WL, Lockey RF. Serum Ig E and human immunodeficiency virus (HIV) infection. J Allergy Clin Immunol. 1990;85(2):445-52. 9. Blanche P, Bachmeyer C, Buvry C, Sicard D Hyperimmunoglobulinemia E syndrome in HIV infection. J Am Acad of Dermatol. 1997; 36(1):106-7. 10. Corominas M, Garcia JF, Mestre M, Fernandez VP, Buendia E. Predictors of atopy in HIV infected patients. Ann Allergy Asthma Immunol. 2000;84(6):607-11. 11. Bowser CS, Kaye J, Joks RO, Charlot C_A, Moallem HJ. Ig E and atopy in perinataly HIV-infected children. Pediatr Allergy Immunol. 2007;18(4):298-303. 12. Bacot BK, Paul ME, Navarro M, Abramson SL, Kline MW, Hanson C, et al. Objective measures of allergic disease in children with human immunodeficiency virus infection. J Allergy Clin Immunol. 1997;100(5):707-11. 13. Linstow ML, Porsbjerg C, Ulrik CS, Christensen SN, Backer V. Prevalence and predictors of atopy amoung young adult Danish. Clin Exp Allergy. 2002;32(4):520-5. 14. Van De Ven M, Van Den Eijnden R, Engel RCME. Atopic diseases and related risk factor among Dutch adolescents. Eur.J of Public Health. 2006;16(5):549-58. 15. Fagan JK, Scheff PA, Hryhorczuk, et al. Prevalence of asthma and other allergic diseases in adolescent population: association with gender and race. Ann Allergy Asthma Immunol. 2001;86(2):177-84. 16. Meinert R, Frischer T, Karmaus W, Kuehr J. Influence of skin prick test criteria on estimation of prevalence and incidence of allergic sensitization in children. Allergy. 1994;49(7):526–32. 17. Goetz DW, Webb EL Jr, Whisman BA, Freeman TM. Aeroallergenspecific IgE changes in individuals with rapid human immunodeficiency virus disease progression. Ann Allergy Asthma Immunol. 1997; 78(3):301-6. 18. Clerrici M, Sarin A, Coffman RL, Wynn TA, Blatt SP, Hendrix CW, et al. Type 1/type2 cytokine modulation of T cell programed cell death as a model for human immunodeficiency virus pathogenesis. Proc Natl Acad Sci USA. 1994;91(25):1181-5. 19. Galhardo MCG, Perez M, Morgado MG, Almeida S, Azevedo LMS, Ferreira H et all. Search of evidence of a Th2 profile in HIV+ patients. Int J Dermatol. 2000;39(2):109-15. 20. Douglas SD, Durako S, Sullivan KE, Camarca M, Moscicki AB, Wilson CM. TH1 and TH2 cytokine mRNA and protein levels in HIV seropositive and HIV seronegative patients. Clin Diagn Lab Immunol. 2003; 10(3):399-404. 21. Hussain I, Smith J. Evidence for the transmissibility of atopy. Chest. 2003;124(5):1968-1974. 22. Uekert SJ, Akan G, Evans MD, Li Zhanhai, Roberg K, Tisler C, DaSilva D et al. Sex related differences in immune development and the expression of atopy in early childhood. J Allergy Clin Immunol. 2006;118(6):1375-81. 23. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worlwide variation in prevalenceof symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema. Lancet. 1998;351(9111):225-32. 24. Rancinan C, Morlat P, Chene G. Prevalence of clinical manifestations of allergic reactions in HIV infection. Cross sectional study of 115 subjects. Rev Med Interne. 1997;18(9):691-4. 25. Empson M, Bishop A, Nightingale B, Garsia R. Atopy, anergic status, and cytokine expression in HIV-infected subjects. J Allergy Clin Immunol. 1999;103(5 Pt 1):833-42. 26. Nair MPN, Schwartz SA, Polasani R, Hou J, Sweet A, Chadha KC. Immunoregulatory effects of morphine on Human Lymphocytes. Clin Diagn Lab Immunol. 1997;4(2):127-32. 27. Cygan J, Trunsky M, Corbridge T. Inhaled Heroine-induced status asthmaticus: five cases and a review of literature. Chest. 2000;117(1):272-5. 28. Greeneltch KM, Kelly Welch AE, Shi YF, Keegan AD. Chronic Morphine Treatment promotes spesific Th2 cytokine production by murine T cells in vitro via Fas/Fas ligand dependent mechanism. J Immnuol. 2005;175(8):4999-5005. 29. Rook EJ, Van Zanten AP, Van den Brink W, Van Ree JM, Heijnen JH. Mast cell mediator tryptase level after inhalation or intravenous administration of high doses pharmaceutically prepared heroine. Drug Alcohol Depend. 2006;85(3):185–90. 30. Vigano A, Principi N, Crupi L, Onorato J, Vincenzo ZG, Salvagio A. Elevation of Ig E in HIV infected children and its correlation with the progression of disease. J Allergy Clin Immunol. 1995;95(2):627-32. 31. Israel-Biet D, Labrousse F, Tourani JM, Sors H, Andrieu JM, Even P. Elevation of Ig E in HIV infected subjects: a marker of poor prognosis. J Allergy Clin Immunol. 1992;89(1 Pt 1):68-75. 32. Koutsonikolis A, Nelson RP, Fernandez-Caldas E, Brigino EM, Seleznick M, Good RA, Lockey RF. Serum total and specific IgE levels in children infected with human immunodeficiency virus. J Allergy Clin Immunol. 1996;97(2):692-7. 33. Klein SA, Dobmeyer JM, Pape M, Ottman OG, Helm EB, Hoelzer D. Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry. AIDS. 1997;11(9):1111-8.

Download

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.